Covered recipient · General Payments record
STEVEN R DELMAESTRO
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2020–2024
$638.23
- Reported across 32 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $266.12 | 15 |
| Gift | $85.00 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| MannKind Corporation | $148.84 | 6 |
| Novo Nordisk AS | $68.00 | 3 |
| GlaxoSmithKline, LLC. | $46.50 | 3 |
| Lilly USA, LLC | $35.69 | 2 |
| PFIZER INC. | $32.76 | 2 |
| Exact Sciences Corporation | $19.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Exact Sciences Corporation | $19.33 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114632411 | CMS |
| GlaxoSmithKline, LLC. | $15.55 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116470842 | CMS |
| GlaxoSmithKline, LLC. | $15.55 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116275213 | CMS |
| GlaxoSmithKline, LLC. | $15.40 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116224983 | CMS |
| Lilly USA, LLC | $16.98 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135428830 | CMS |
| Lilly USA, LLC | $18.71 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135434465 | CMS |
| Mannkind Corporation | $10.15 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145841055 | CMS |
| Mannkind Corporation | $24.20 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145841057 | CMS |
| Mannkind Corporation | $11.00 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145841059 | CMS |
| Mannkind Corporation | $42.50 | 09/25/2024 | Gift | Undisputed | 01/23/2026 | 1145841061 | CMS |
| Mannkind Corporation | $42.50 | 09/25/2024 | Gift | Undisputed | 01/23/2026 | 1145841063 | CMS |
| Mannkind Corporation | $18.49 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145841065 | CMS |
| Novo Nordisk Inc | $25.00 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096895097 | CMS |
| Novo Nordisk Inc | $21.60 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096621154 | CMS |
| Novo Nordisk Inc | $21.40 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096826334 | CMS |
| PFIZER INC. | $18.81 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132039236 | CMS |
| PFIZER INC. | $13.95 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131258103 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.